1. Home
  2. CDNA vs XRX Comparison

CDNA vs XRX Comparison

Compare CDNA & XRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • XRX
  • Stock Information
  • Founded
  • CDNA 1998
  • XRX 1906
  • Country
  • CDNA United States
  • XRX United States
  • Employees
  • CDNA N/A
  • XRX N/A
  • Industry
  • CDNA Medical Specialities
  • XRX Computer peripheral equipment
  • Sector
  • CDNA Health Care
  • XRX Technology
  • Exchange
  • CDNA Nasdaq
  • XRX Nasdaq
  • Market Cap
  • CDNA 1.1B
  • XRX 1.1B
  • IPO Year
  • CDNA 2014
  • XRX N/A
  • Fundamental
  • Price
  • CDNA $22.94
  • XRX $8.38
  • Analyst Decision
  • CDNA Buy
  • XRX Sell
  • Analyst Count
  • CDNA 8
  • XRX 4
  • Target Price
  • CDNA $26.43
  • XRX $9.50
  • AVG Volume (30 Days)
  • CDNA 823.5K
  • XRX 2.6M
  • Earning Date
  • CDNA 02-26-2025
  • XRX 01-28-2025
  • Dividend Yield
  • CDNA N/A
  • XRX 11.88%
  • EPS Growth
  • CDNA N/A
  • XRX N/A
  • EPS
  • CDNA N/A
  • XRX N/A
  • Revenue
  • CDNA $312,775,000.00
  • XRX $6,221,000,000.00
  • Revenue This Year
  • CDNA $20.27
  • XRX $2.96
  • Revenue Next Year
  • CDNA $11.76
  • XRX N/A
  • P/E Ratio
  • CDNA N/A
  • XRX N/A
  • Revenue Growth
  • CDNA 5.26
  • XRX N/A
  • 52 Week Low
  • CDNA $7.42
  • XRX $8.02
  • 52 Week High
  • CDNA $34.84
  • XRX $19.48
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 53.43
  • XRX 38.77
  • Support Level
  • CDNA $21.96
  • XRX $8.40
  • Resistance Level
  • CDNA $23.80
  • XRX $9.91
  • Average True Range (ATR)
  • CDNA 1.53
  • XRX 0.44
  • MACD
  • CDNA 0.09
  • XRX -0.11
  • Stochastic Oscillator
  • CDNA 45.88
  • XRX 2.40

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

About XRX Xerox Holdings Corporation

Xerox Holdings Corp is an original equipment manufacturing and software company. Xerox operates in one segment--design, development, and sale of printing technology and related solutions--while deriving 60% of its revenue from the U.S. and 40% from international markets. The company is an OEM of multifunction printers, or MFPs (printers that can print, copy, and scan), focusing on large enterprise markets. Apart from equipment, the company provides post-sales services like managed print services--a service that helps to bring smart servicing and efficiencies to how employers use their print/copy equipment. Xerox is attempting to enter new markets like digital print packaging solutions and printed electronics.

Share on Social Networks: